|
US2900415A
(en)
|
1954-12-14 |
1959-08-18 |
Lakeside Lab Inc |
Synthesized antispasmodic compounds
|
|
CH498122A
(de)
|
1968-02-09 |
1970-10-31 |
Geigy Ag J R |
Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
|
|
CH481110A
(de)
|
1967-02-17 |
1969-11-15 |
Geigy Ag J R |
Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
|
|
CH500194A
(de)
|
1968-02-15 |
1970-12-15 |
Ciba Geigy Ag |
Verfahren zur Herstellung von Tetrahydroazepinderivaten
|
|
GB1268243A
(en)
|
1968-03-11 |
1972-03-22 |
Wallace & Tiernan Inc |
0,2,4,5,-tetrahydro-3h,3-benzazepines
|
|
US4233217A
(en)
|
1968-03-11 |
1980-11-11 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H, 3 benzazepines
|
|
FR314F
(cg-RX-API-DMAC7.html)
|
1968-03-22 |
1970-05-25 |
|
|
|
FR7736M
(cg-RX-API-DMAC7.html)
|
1968-09-02 |
1970-03-09 |
|
|
|
US3716639A
(en)
|
1970-03-11 |
1973-02-13 |
Ciba Geigy Corp |
Anorexigenic tetrahydrobenzazepines
|
|
US3795683A
(en)
|
1970-08-19 |
1974-03-05 |
Hoffmann La Roche |
2,3,4,5-tetrahydro-1h-3-benzazepines
|
|
LU65954A1
(cg-RX-API-DMAC7.html)
|
1972-08-25 |
1974-03-07 |
|
|
|
US4210749A
(en)
|
1974-11-12 |
1980-07-01 |
Pennwalt Corporation |
Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
|
|
SE7510988L
(sv)
|
1975-10-01 |
1977-04-02 |
Draco Ab |
Nya farmaceutiskt aktiva foreningar
|
|
US4111957A
(en)
|
1977-02-02 |
1978-09-05 |
Smithkline Corporation |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
|
|
US4108989A
(en)
|
1977-04-01 |
1978-08-22 |
Smithkline Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones
|
|
DE2758001A1
(de)
|
1977-12-24 |
1979-07-12 |
Hoechst Ag |
Cephalosporinderivate und verfahren zu ihrer herstellung
|
|
CA1090797A
(en)
|
1978-06-20 |
1980-12-02 |
Kenneth G. Holden |
Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1h- 3-benzazepine compounds
|
|
AU515236B2
(en)
|
1978-06-26 |
1981-03-26 |
Smithkline Corporation |
Substituted-1-thienyl and furyl-2,3,4,5-tetrahydro-14-3 benzazepine derivatives
|
|
ZA792785B
(en)
|
1978-07-07 |
1980-08-27 |
Smithkline Corp |
Mercapto substituted-2,3,4,5-tetrahydro-1h-3-benzazepines
|
|
IE50355B1
(en)
|
1979-10-20 |
1986-04-02 |
Wyeth John & Brother Ltd |
Morpholine derivatives
|
|
US4477378A
(en)
|
1980-02-05 |
1984-10-16 |
Schering Corp. |
Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
|
|
EP0080779B1
(en)
|
1981-11-27 |
1986-07-16 |
Smithkline Beckman Corporation |
3-benzazepines as alpha-2 antagonists
|
|
ZA827887B
(en)
|
1981-11-27 |
1983-11-30 |
Smithkline Beckman Corp |
Pharmaceutical compositions and method of producing alpha2 antagonism
|
|
FR2518544A1
(fr)
|
1981-12-22 |
1983-06-24 |
Lipha |
Benzodiazepines-1,3 thione-2, procede de preparation et medicament les contenant
|
|
FR2525603A1
(fr)
|
1982-04-27 |
1983-10-28 |
Adir |
Benzoazacycloalkyl-spiro-imidazolinines, leur preparation et leur application en therapeutique
|
|
US4988690A
(en)
|
1982-06-14 |
1991-01-29 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryloxy-2,3,4,5-tetrahydro-3-benzazepines and anti-depressant use thereof
|
|
DE3418270A1
(de)
|
1984-05-17 |
1985-11-21 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue aminotetralinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US4541954A
(en)
|
1984-09-05 |
1985-09-17 |
Smithkline Beckman Corporation |
Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine
|
|
EP0204349A3
(de)
|
1985-06-01 |
1990-01-03 |
Dr. Karl Thomae GmbH |
Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
EG18188A
(en)
|
1986-05-01 |
1992-09-30 |
Pfizer Ltd |
Process for preparation anti-arhythmia agents
|
|
GB8610668D0
(en)
|
1986-05-01 |
1986-06-04 |
Pfizer Ltd |
Anti-arrhythmia agents
|
|
US4762845A
(en)
|
1986-05-21 |
1988-08-09 |
Abbott Laboratories |
7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
|
|
EP0285287A3
(en)
|
1987-03-23 |
1990-08-16 |
Smithkline Beecham Corporation |
3-benzazepine compounds for use in treating gastrointestinal motility disorders
|
|
US5247080A
(en)
|
1987-03-27 |
1993-09-21 |
Schering Corporation |
Substituted benzazepines useful as intermediates for producing pharmaceutically active compounds
|
|
ZA882080B
(en)
|
1987-03-27 |
1989-04-26 |
Schering Corp |
Substituted benzazepines,their preparation and pharmaceutical compositions containing them
|
|
US5015639A
(en)
|
1987-03-27 |
1991-05-14 |
Schering Corporation |
Substituted benzazepines, their preparation and pharmaceutical compositions containing them
|
|
WO1988007858A1
(en)
|
1987-04-09 |
1988-10-20 |
Smithkline Beckman Corporation |
Sulfinyl and sulfonyl substituted 3-benzazepines
|
|
US4957914A
(en)
|
1987-05-15 |
1990-09-18 |
Syntex (U.S.A.) Inc. |
1,9-alkano-bridged-2,3,4,5-tetrahydro-1H-3-benzazepines
|
|
DK107688D0
(da)
|
1988-03-01 |
1988-03-01 |
Novo Industri As |
Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
|
|
US5422355A
(en)
|
1989-06-02 |
1995-06-06 |
John Wyeth & Brother, Limited |
Composition for treating depression with (N-heteroaryl)alkylamines
|
|
US5178786A
(en)
|
1989-08-04 |
1993-01-12 |
The Lubrizol Corporation |
Corrosion-inhibiting compositions and functional fluids containing same
|
|
CA2037162A1
(en)
|
1990-03-12 |
1991-09-13 |
Steven Howard Shaber |
Heterocyclicacetonitriles and fungicidal use
|
|
AU8201591A
(en)
|
1990-06-15 |
1992-01-07 |
Schering Corporation |
8-lower alkyl-5-cycloalkyl or 5-cycloalkenyl substitued benzazepines and pharmaceutical compositions containing them
|
|
US5275915A
(en)
|
1991-06-05 |
1994-01-04 |
Dainippon Ink And Chemicals, Inc. |
Developer for light-sensitive material
|
|
PT100602A
(pt)
*
|
1991-06-21 |
1993-09-30 |
Smithkline Beecham Plc |
Uso de derivados de tetra-hidrobenzazepinas, derivados de tetra-hidrobenzazepinas,sua preparacao e composicoes farmaceuticas que os contem
|
|
GB9116824D0
(en)
|
1991-08-05 |
1991-09-18 |
Smithkline Beecham Corp |
Chemical compounds
|
|
EP0558824A1
(en)
|
1992-02-04 |
1993-09-08 |
Duphar International Research B.V |
Method for the preparation of vicinal aminoalcohols and optically active O-protected derivatives thereof
|
|
US5241065A
(en)
|
1992-02-25 |
1993-08-31 |
Schering Corporation |
2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
|
|
JPH05339263A
(ja)
|
1992-06-08 |
1993-12-21 |
Wakunaga Pharmaceut Co Ltd |
ジヒドロピリジン誘導体
|
|
JPH06298746A
(ja)
|
1993-04-19 |
1994-10-25 |
Showa Denko Kk |
環状イミド酸エステルの製造法
|
|
AU7177694A
(en)
|
1993-06-23 |
1995-01-17 |
Cambridge Neuroscience, Inc. |
Sigma receptor ligands and the use thereof
|
|
US5387685A
(en)
|
1993-07-16 |
1995-02-07 |
American Cyanamid Co |
MDR reversal agents
|
|
GB9322976D0
(en)
|
1993-11-08 |
1994-01-05 |
Pfizer Ltd |
Therapeutic agents
|
|
DE4419315A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
|
DE4419247A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
|
|
DE4419246A1
(de)
|
1994-06-01 |
1995-12-07 |
Merckle Gmbh |
Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
|
|
DE4427838A1
(de)
|
1994-08-05 |
1996-02-08 |
Thomae Gmbh Dr K |
Kondensierte Azepinderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
DE4429079A1
(de)
|
1994-08-17 |
1996-02-22 |
Thomae Gmbh Dr K |
Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
JPH08134048A
(ja)
|
1994-11-08 |
1996-05-28 |
Sumitomo Chem Co Ltd |
オキサゾリン類の製造法
|
|
GB9508622D0
(en)
|
1995-04-28 |
1995-06-14 |
Pfizer Ltd |
Therapeutic agants
|
|
JPH0930960A
(ja)
|
1995-07-18 |
1997-02-04 |
Takasago Internatl Corp |
真菌感染症治療剤
|
|
JPH0987258A
(ja)
|
1995-09-28 |
1997-03-31 |
Sumitomo Chem Co Ltd |
オキサゾリン類、その製造方法およびそれを用いる不斉シクロプロパンカルボン酸類の製造方法
|
|
CA2190708A1
(en)
|
1995-12-08 |
1997-06-09 |
Johannes Aebi |
Aminoalkyl substituted benzo-heterocyclic compounds
|
|
US5892116A
(en)
|
1996-01-03 |
1999-04-06 |
Georgetown University |
Gelators
|
|
US5925651A
(en)
|
1996-04-03 |
1999-07-20 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
US5691362A
(en)
|
1996-06-05 |
1997-11-25 |
Schering-Plough Corporation |
Substituted benzene-fused hetero- and carbocyclics as nuerokinin antagonists
|
|
JP2001501172A
(ja)
|
1996-08-15 |
2001-01-30 |
スミスクライン・ビーチャム・コーポレイション |
Ｉｌ―８レセプターアンタゴニスト
|
|
US5908830A
(en)
|
1996-10-31 |
1999-06-01 |
Merck & Co., Inc. |
Combination therapy for the treatment of diabetes and obesity
|
|
AU6290998A
(en)
|
1997-03-07 |
1998-09-29 |
Novo Nordisk A/S |
4,5,6,7-tetrahydro-thieno{3,2-c}pyridine derivatives, their preparation and use
|
|
US5795895A
(en)
|
1997-06-13 |
1998-08-18 |
Anchors; J. Michael |
Combination anorexiant drug therapy for obesity using phentermine and an SSRI drug
|
|
AUPP020297A0
(en)
|
1997-11-05 |
1997-11-27 |
University Of Melbourne, The |
A novel receptor, and compounds which bind thereto
|
|
DE69941777D1
(de)
|
1998-03-10 |
2010-01-21 |
Ono Pharmaceutical Co |
Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
|
|
JP3603177B2
(ja)
|
1998-03-26 |
2004-12-22 |
参天製薬株式会社 |
新規ウレア誘導体
|
|
CA2325741C
(en)
|
1998-03-26 |
2007-05-08 |
Santen Pharmaceutical Co., Ltd. |
Urea derivatives having tnf- .alpha. production inhibitory effects
|
|
GB9807354D0
(en)
*
|
1998-04-07 |
1998-06-03 |
Glaxo Group Ltd |
Antiviral compound
|
|
EP0987235B1
(en)
|
1998-08-25 |
2003-03-12 |
MERCK PATENT GmbH |
Method for the conversion of arenes or alkenes with iodoalkenes, aryl iodides or arenediazonium salts
|
|
US7141593B1
(en)
*
|
1999-06-04 |
2006-11-28 |
Abbott Laboratories |
Pharmaceutical formulations
|
|
US20080103179A1
(en)
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
|
ATE254614T1
(de)
|
1999-08-06 |
2003-12-15 |
Hoffmann La Roche |
Tetrahydro-benzo(d)azepine und deren verwendung als metabotrope glutamatrezeptor-antagonisten
|
|
EP1074549B1
(en)
|
1999-08-06 |
2003-11-19 |
F. Hoffmann-La Roche Ag |
Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors
|
|
JP2001076413A
(ja)
|
1999-09-06 |
2001-03-23 |
Sony Corp |
フレキシブル磁気ディスク用ヘッドスライダー
|
|
US6403657B1
(en)
|
1999-10-04 |
2002-06-11 |
Martin C. Hinz |
Comprehensive pharmacologic therapy for treatment of obesity
|
|
DE10003708A1
(de)
|
2000-01-28 |
2001-08-02 |
Solvent Innovation Gmbh |
Neuartige chirale ionische Flüssigkeiten und Verfahren zu ihrer Darstellung in enantiomerenreiner oder enantiomerenangereicherter Form
|
|
US7157466B2
(en)
|
2000-06-30 |
2007-01-02 |
Smithkline Beecham (Cork) Limited |
Quinazoline ditosylate salt compounds
|
|
AU2303402A
(en)
|
2000-11-14 |
2002-05-27 |
Smithkline Beecham Plc |
Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
|
|
DE10057751A1
(de)
|
2000-11-22 |
2002-05-23 |
Bayer Ag |
Neue Carbamat-substituierte Pyrazolopyridinderivate
|
|
GB0030710D0
(en)
|
2000-12-15 |
2001-01-31 |
Hoffmann La Roche |
Piperazine derivatives
|
|
JPWO2002074746A1
(ja)
|
2001-03-16 |
2004-07-08 |
山之内製薬株式会社 |
ベンゾアゼピン誘導体
|
|
GB0111186D0
(en)
*
|
2001-05-08 |
2001-06-27 |
Smithkline Beecham Plc |
Novel compounds
|
|
KR100574153B1
(ko)
*
|
2001-05-22 |
2006-04-25 |
화이자 프로덕츠 인코포레이티드 |
아지트로마이신의 결정형
|
|
US6825198B2
(en)
|
2001-06-21 |
2004-11-30 |
Pfizer Inc |
5-HT receptor ligands and uses thereof
|
|
US20030119060A1
(en)
*
|
2001-08-10 |
2003-06-26 |
Desrosiers Peter J. |
Apparatuses and methods for creating and testing pre-formulations and systems for same
|
|
AU2002356525A1
(en)
|
2001-09-24 |
2003-04-07 |
Elan Pharmaceuticals, Inc. |
Substituted amines for the treatment of neurological disorders
|
|
EP1456178A1
(en)
|
2001-12-21 |
2004-09-15 |
Smithkline Beecham Plc |
7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders
|
|
AU2002367323A1
(en)
|
2001-12-28 |
2003-07-24 |
Bayer Pharmaceuticals Corporation |
Benzothieno (3,2-
|
|
CA2473740A1
(en)
|
2002-01-18 |
2003-07-31 |
David Solow-Cordero |
Methods of treating conditions associated with an edg receptor
|
|
WO2003077847A2
(en)
|
2002-03-12 |
2003-09-25 |
Merck & Co., Inc. |
Substituted amides
|
|
WO2003086303A2
(en)
|
2002-04-12 |
2003-10-23 |
The University Of Chicago |
Farnesoid x-activated receptor agonists
|
|
US6953787B2
(en)
*
|
2002-04-12 |
2005-10-11 |
Arena Pharmaceuticals, Inc. |
5HT2C receptor modulators
|
|
DE10220570A1
(de)
|
2002-05-08 |
2003-11-20 |
Bayer Ag |
Carbamat-substituierte Pyrazolopyridine
|
|
US6821502B2
(en)
*
|
2002-06-12 |
2004-11-23 |
Chevron U.S.A. Inc. |
Method of making aluminum-containing zeolite with IFR structure
|
|
GB0224557D0
(en)
|
2002-10-22 |
2002-11-27 |
Glaxo Group Ltd |
Novel compounds
|
|
DE10261131A1
(de)
|
2002-12-20 |
2004-07-01 |
Grünenthal GmbH |
Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide
|
|
US7145012B2
(en)
|
2003-04-23 |
2006-12-05 |
Pfizer Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
US7232823B2
(en)
|
2003-06-09 |
2007-06-19 |
Pfizer, Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
EA016485B1
(ru)
*
|
2003-06-17 |
2012-05-30 |
Арена Фармасьютикалз, Инк. |
Способы получения 3-бензазепинов
|
|
BRPI0411470A
(pt)
*
|
2003-06-17 |
2006-07-11 |
Arena Pharm Inc |
derivados de benzazepina úteis para o tratamento de doenças associadas com o receptor de 5ht2c
|
|
EP1644347A1
(en)
|
2003-06-20 |
2006-04-12 |
Arena Pharmaceuticals, Inc. |
N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT sb 2C /sb RECEPTOR ASSOCIATED DISEASES
|
|
TW200510324A
(en)
*
|
2003-08-11 |
2005-03-16 |
Lilly Co Eli |
6-(2,2,2-trifluoroethylamino)-7-chiloro-2, 3, 4, 5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
|
|
EP1667791A1
(en)
*
|
2003-10-06 |
2006-06-14 |
Solvias AG |
Process for the parallel detection of crystalline forms of molecular solids
|
|
US20080009478A1
(en)
|
2003-10-22 |
2008-01-10 |
Arena Pharmaceuticals, Inc. |
Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
|
|
WO2005042490A1
(en)
|
2003-10-22 |
2005-05-12 |
Arena Pharmaceuticals, Inc. |
Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases
|
|
AR047541A1
(es)
*
|
2004-02-13 |
2006-01-25 |
Sandoz Ag |
Fosfato de 5-[[4-[2-metil-2-piridinil-amino-etoxi]fenil]metil]-2,4 tiazolidinadiona (rosiglitazona) y sus formas polimorficas
|
|
PT1720836E
(pt)
*
|
2004-02-25 |
2014-07-16 |
Lilly Co Eli |
2,3,4,5-tetra-hidro-1h-benzo[d]azepinas 6-substituídas como agonistas do recetor 5-ht2c
|
|
SE0401871D0
(sv)
|
2004-07-15 |
2004-07-15 |
Glucogene Medical Hfm Ab |
New compositions
|
|
US7351833B2
(en)
*
|
2004-07-23 |
2008-04-01 |
Abbott Laboratories |
(1S,5S)-3-(5,6-dichloropyridin-3-yl)-3,6-diazabicyclo[3.2.0]heptane benzenesulfonate
|
|
CA2575928A1
(en)
|
2004-08-02 |
2006-02-09 |
Genmedica Therapeutics Sl |
Compounds for inhibiting copper-containing amine oxidases and uses thereof
|
|
US8178077B2
(en)
|
2004-10-19 |
2012-05-15 |
Reverse Proteomics Research Institute Co., Ltd. |
Drug development target protein and target gene, and method of screening
|
|
NZ555981A
(en)
|
2004-12-21 |
2011-01-28 |
Arena Pharm Inc |
Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
|
|
CN102631349A
(zh)
*
|
2004-12-23 |
2012-08-15 |
艾尼纳制药公司 |
5HT2c受体调节剂组合物和使用方法
|
|
US8436176B2
(en)
*
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
UA91546C2
(uk)
*
|
2005-05-03 |
2010-08-10 |
Бьорінгер Інгельхайм Інтернаціональ Гмбх |
КРИСТАЛІЧНА ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПІРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГІДРОФУРАН-3-ІЛОКСИ)-БЕНЗИЛ]-БЕНЗОЛУ, СПОСІБ ЇЇ ОДЕРЖАННЯ ТА ЇЇ ЗАСТОСУВАННЯ ПРИ ПРИГОТУВАННІ ЛІКАРСЬКИХ ЗАСОБІВ
|
|
MY152185A
(en)
*
|
2005-06-10 |
2014-08-29 |
Novartis Ag |
Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
|
|
KR20130087059A
(ko)
*
|
2005-08-29 |
2013-08-05 |
사노피-아벤티스 유.에스. 엘엘씨 |
피리다지노［4,5-ｂ］인돌 유도체의 신규 결정질 형태
|
|
JP5165568B2
(ja)
*
|
2005-09-01 |
2013-03-21 |
イーライ リリー アンド カンパニー |
５−ＨＴ２Ｃ受容体アゴニストとしての６−置換−２，３，４，５−テトラヒドロ−１Ｈ−ベンゾ［ｄ］アゼピン
|
|
BRPI0615033A2
(pt)
*
|
2005-09-01 |
2011-04-26 |
Lilly Co Eli |
composto, composição farmacêutica, e, uso de um composto
|
|
WO2007033348A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Sicor, Inc. |
Process for the synthesis of rocuronium bromide
|
|
WO2007120517A2
(en)
|
2006-04-03 |
2007-10-25 |
Arena Pharmaceuticals, Inc. |
Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
|
|
BRPI0717554A2
(pt)
*
|
2006-09-28 |
2013-10-29 |
Merck & Co Inc |
Composição farmacêutica, método para tratar câncer e aliviar os efeitos colaterais do inibidor da hdac, e, método de se obter um complexo de quelato inibidor da hdac de metal
|
|
US7837978B2
(en)
*
|
2006-10-13 |
2010-11-23 |
Chevron U.S.A. Inc. |
Process for preparing aluminum-containing molecular sieve SSZ-26
|
|
ES2522587T3
(es)
|
2006-12-05 |
2014-11-17 |
Arena Pharmaceuticals, Inc. |
Procesos para preparar (R)-8-cloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzacepina e intermedios de la misma
|
|
PE20081506A1
(es)
*
|
2006-12-12 |
2008-12-09 |
Infinity Discovery Inc |
Formulaciones de ansamicina
|
|
JP2010514828A
(ja)
|
2007-01-04 |
2010-05-06 |
プロシディオン・リミテッド |
ピペリジンｇｐｃｒアゴニスト
|
|
US20090270352A1
(en)
*
|
2007-05-22 |
2009-10-29 |
Ultimorphix Technologies B.V. |
Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
|
|
EP2164324B1
(en)
|
2007-06-15 |
2014-08-13 |
University Of Florida Research Foundation |
Therapeutic compounds
|
|
WO2009080691A2
(en)
|
2007-12-20 |
2009-07-02 |
Neurosearch A/S |
Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound
|
|
TW200944520A
(en)
*
|
2008-01-29 |
2009-11-01 |
Glaxo Group Ltd |
Spiro compounds as NPY Y5 receptor antagonists
|
|
WO2009097416A1
(en)
|
2008-01-29 |
2009-08-06 |
Vanda Pharmaceuticals, Inc. |
Imidazolylalkyl- pyridines as dbh inhibitors
|
|
CN102015591B
(zh)
|
2008-03-04 |
2014-01-29 |
艾尼纳制药公司 |
制备与5-ht2c激动剂(r)-8-氯-1-甲基-2，3，4，5-四氢-1h-3-苯并氮杂卓相关的中间体的方法
|
|
WO2009123992A1
(en)
|
2008-03-31 |
2009-10-08 |
Metabolex, Inc. |
Oxymethylene aryl compounds and uses thereof
|
|
BRPI0914891A2
(pt)
|
2008-06-20 |
2015-11-24 |
Metabolex Inc |
agonistas de aril gpr119 e usos dos mesmos
|
|
MX2011002558A
(es)
|
2008-09-10 |
2011-04-26 |
Boehringer Ingelheim Int |
Terapia de combinacion para el tratamiento de diabetes y estados relacionados.
|
|
CN102648170A
(zh)
|
2009-06-18 |
2012-08-22 |
艾尼纳制药公司 |
制备5-ht2c受体激动剂的方法
|
|
AU2010264720A1
(en)
|
2009-06-24 |
2011-12-08 |
Boehringer Ingelheim International Gmbh |
New compounds, pharmaceutical composition and methods relating thereto
|
|
JP2013539470A
(ja)
|
2010-09-01 |
2013-10-24 |
アリーナ ファーマシューティカルズ， インコーポレイテッド |
ロルカセリンと光学活性な酸との塩
|
|
US20130267500A1
(en)
|
2010-09-01 |
2013-10-10 |
Arena Pharmaceuticals, Inc. |
5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level
|
|
CA2808904A1
(en)
*
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Non-hygroscopic salts of 5-ht2c agonists
|
|
SG10201506873WA
(en)
|
2010-09-01 |
2015-10-29 |
Arena Pharm Inc |
Fast-dissolve dosage forms of 5-ht2c agonists
|
|
CA2808890A1
(en)
*
|
2010-09-01 |
2012-03-08 |
Arena Pharmaceuticals, Inc. |
Administration of lorcaserin to individuals with renal impairment
|
|
CN103189053A
(zh)
|
2010-09-01 |
2013-07-03 |
艾尼纳制药公司 |
用于体重控制的5-ht2c激动剂的调节释放剂型
|
|
CN102126988A
(zh)
|
2010-12-17 |
2011-07-20 |
张家港瀚康化工有限公司 |
4-(4-氯苯基)-2-溴甲基-2-苯基丁腈的制备方法
|
|
CA2886875A1
(en)
*
|
2012-10-09 |
2014-04-17 |
Arena Pharmaceuticals, Inc. |
Method of weight management
|